Emeis

13/02/25 -"Considering Emeis’ operational improvements in key countries and progress on its disposal program, we resume a (slightly) positive recommendation on the stock. We remain cautious as 1/ the ..."

PDF page sample
Pages
57
Language
English
Published on
13/02/25
Download
You may also be interested by these reports :
16/05/25
The 2024 EPS benefitted from some one-off tailwinds, in addition to the good cost control. Hence, while the EPS was significantly above estimates, it ...
16/05/25
Bastide’s Q3 revenue extended the positive trend, thanks to the continued strong growth in specialised activities and the recovery in the Homecare ...
16/05/25
We have removed Palantir, a software company with real-time, AI-driven decisions capabilities, from the peer group list due to its elevated ...
15/05/25
Our target price has been adjusted downward due to factors outlined in the EPS section. Additionally, we have reduced the valuation premium on the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO